Subcutaneously administered Menopur(R), a new highly purified human menopausal gonadotropin, causes significantly fewer injection site reactions than Repronex(R) in subjects undergoing in vitro fertilization

BACKGROUND: The safety and tolerability of a new highly purified, urine-derived human menopausal gonadotropin (hMG) preparation [Menopur(R)] was compared with a currently available hMG [Repronex (R)] in women undergoing in vitro fertilization (IVF). METHODS: This was a randomized, open-label, parall...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Keye, William R, Webster, Bobby, Dickey, Richard, Somkuti, Stephen, Crain, Jack, Scobey, M Joseph
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2005
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1309620/
https://ncbi.nlm.nih.gov/pubmed/16280073
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-7827-3-62
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados